


Ask a doctor about a prescription for DICLOFENAC CINFA 50 mg GASTRO-RESISTANT TABLETS
Package Leaflet: Information for the User
diclofenaco cinfa 50 mg gastro-resistant tablets EFG
diclofenaco sodium
Read all of this leaflet carefully before you start taking this medicine because it contains important information for you.
Contents of the pack and other information
Diclofenaco sodium, the active ingredient in diclofenaco cinfa, belongs to a group of medicines called non-steroidal anti-inflammatory drugs (NSAIDs) used to treat pain and inflammation.
diclofenaco cinfa is used to treat the following conditions:
Post-traumatic inflammation.
It is important that you use the smallest dose that relieves or controls your pain and do not take this medicine for longer than necessary to control your symptoms.
Do not takediclofenaco cinfa
Make sure your doctor knows before taking diclofenaco:
Side effects can be minimized by using the lowest effective dose for the shortest possible time.
Warnings and precautions
Consult your doctor or pharmacist before starting to take diclofenaco cinfa
This risk is greater when high doses and prolonged treatments are used, in patients with a history of peptic ulcer and in elderly patients. In these cases, your doctor will consider the possibility of associating a stomach protective medication.
Tell your doctor
Patients with cardiovascular problems
Medicines like diclofenaco may be associated with an increased risk of heart attacks ("myocardial infarction") or strokes, especially when used in high doses and for prolonged treatments. Do not exceed the recommended dose or duration of treatment. If you have heart problems, a history of strokes, or think you may be at risk of having them (for example, you have high blood pressure, diabetes, high cholesterol, or triglycerides, or are a smoker) and your doctor decides to treat you with diclofenaco, you should not take more than 100 mg per day if the treatment lasts more than 4 weeks.
Also, this type of medicine can cause fluid retention, especially in patients with heart disease and/or high blood pressure (hypertension).
In general, it is very important to take the lowest effective dose of diclofenaco for the shortest possible time that relieves your pain and/or inflammation to reduce the risk of cardiovascular side effects. If you notice chest pain, shortness of breath, weakness, or difficulty speaking while taking diclofenaco, contact your doctor immediately.
Children and adolescents
The use of this medicine is not recommended in children and adolescents under 14 years of age.
Use in elderly patients
Elderly patients, especially those who are frail or have low body weight, may be more sensitive to the effects of diclofenaco than other adults. Therefore, it is especially important that elderly patients inform their doctor immediately of any side effects that occur.
Other medicines and diclofenaco cinfa
Tell your doctor or pharmacist if you are taking, have recently taken, or might take any other medicines.
Certain medicines may interfere with diclofenaco: in these cases, it may be necessary to change the dose or interrupt treatment with one of them.
It is important that you inform your doctor if you are taking or have recently taken any of the following medicines:
Takingdiclofenaco cinfawith food, drinks, and alcohol
This medicine should be taken preferably before meals or on an empty stomach because it delays the onset of the effect.
Consuming alcoholic beverages with diclofenaco may increase its toxicity.
Pregnancy and breastfeeding
If you are pregnant or breastfeeding, think you may be pregnant, or are planning to have a baby, ask your doctor or pharmacist for advice before taking this medicine.
Pregnancy
Do not take diclofenaco if you are in the last 3 months of pregnancy, as it may harm your baby or cause problems during delivery. It may cause kidney and heart problems in your baby. It may affect your tendency and that of your baby to bleed and delay or prolong delivery more than expected. Because the administration of medicines like diclofenaco has been associated with an increased risk of congenital anomalies/spontaneous abortions, it is not recommended during the first and second trimester of pregnancy unless strictly necessary and as indicated by your doctor. In these cases, the dose and duration will be limited to the minimum possible. From the 20th week of pregnancy, diclofenaco may cause kidney problems in your baby if taken for more than a few days, which can cause low levels of the fluid that surrounds the baby (oligohydramnios) or narrowing of a blood vessel (ductus arteriosus) in the baby's heart. If you need treatment for more than a few days, your doctor may recommend additional checks.
For women of childbearing age, it should be noted that medicines like diclofenaco have been associated with a decrease in fertility.
Breastfeeding
Ask your doctor or pharmacist for advice before taking any medicine.
Small amounts of diclofenaco may appear in breast milk, so you should not take diclofenaco if you are breastfeeding.
Driving and using machines
The influence of diclofenaco on the ability to drive and use machines is negligible or minimal; however, patients who experience visual disturbances, dizziness, vertigo, somnolence, or other central nervous system disorders while taking diclofenaco should avoid driving vehicles or operating machinery.
diclofenaco cinfa contains lactose.
This medicine contains lactose. If your doctor has told you that you have an intolerance to some sugars, consult them before taking this medicine.
diclofenaco cinfa contains sodium.
This medicine contains less than 1 mmol of sodium (23 mg) per tablet; this is essentially "sodium-free".
Follow exactly the administration instructions of this medicine given by your doctor or pharmacist. In case of doubt, consult your doctor or pharmacist again.
Remember to take your medicine.
Use in adults and children over 14 years
The recommended dose for milder cases is 100 mg (one tablet twice a day). Do not exceed the dose of 150 mg (3 tablets) per day. The total daily dose should be divided into 2 or 3 divided doses.
In menstrual pain, the daily dose, which should be adjusted individually, is 50-200 mg (1 to 4 tablets). An initial dose of 50-100 mg (1 to 2 tablets) will be administered, and if necessary, it will be increased in subsequent menstrual cycles. Treatment should be started when the first symptoms appear. Depending on the intensity, it will be continued for a few days.
Method of administration
The tablets should be swallowed whole with a glass of water or other liquid, without dividing or chewing them. Take diclofenaco preferably before meals or on an empty stomach (see section "Taking diclofenaco cinfa with food, drinks, and alcohol").
If you take morediclofenaco cinfathan you should
In case of overdose or accidental ingestion, consult your doctor or pharmacist immediately or call the Toxicology Information Service, phone 91 562 04 20, indicating the medicine and the amount taken.
If you forget to takediclofenaco cinfa
Do not take a double dose to make up for forgotten doses.
Like all medicines, this medicine can cause adverse effects, although not all people suffer from them.
Some adverse effects can be serious.
Stop using this medicine and consult your doctor immediately if you notice:
Mild abdominal colic and abdominal pain on palpation that begins shortly after starting treatment with diclofenac followed by rectal bleeding or bloody diarrhea, usually observed within 24 hours after the onset of abdominal pain (frequency not known, cannot be determined from available data).
Chest pain, which can be a sign of a potentially serious allergic reaction called Kounis syndrome.
Severe skin allergic reaction, which can include large red or dark spots, skin swelling, blisters, and itching (generalized fixed drug eruption).
Other adverse effects that have been reported with the use of diclofenac are the following:
Frequent Adverse Effects (may affect up to 1 in 10 people):
Nervous System Disorders
Ear and Labyrinth Disorders
Gastrointestinal Disorders
Hepatobiliary Disorders
Skin and Subcutaneous Tissue Disorders
Infrequent Adverse Effects (may affect up to 1 in 100 people):
Cardiac Disorders(at high doses during prolonged treatments)
If these symptoms appear, consult your doctor immediately
Rare Adverse Effects (may affect up to 1 in 1,000 people):
Immune System Disorders
If these symptoms appear, consult your doctor immediately
Nervous System Disorders
If these symptoms appear, inform your doctor immediately
Respiratory, Thoracic, and Mediastinal Disorders
Gastrointestinal Disorders
If these symptoms appear, consult your doctor immediately
Hepatobiliary Disorders
If these symptoms appear, consult your doctor immediately
Skin and Subcutaneous Tissue Disorders
General Disorders and Administration Site Conditions
Very Rare Adverse Effects (may affect up to 1 in 10,000 people):
Blood and Lymphatic System Disorders
If these symptoms appear, consult your doctor immediately
Immune System Disorders
Psychiatric Disorders
Nervous System Disorders
If these symptoms appear, consult your doctor immediately
Eye Disorders
Ear and Labyrinth Disorders
Vascular Disorders
Respiratory, Thoracic, and Mediastinal Disorders
If these symptoms appear, consult your doctor immediately
Gastrointestinal Disorders
If these symptoms appear, consult your doctor immediately
Skin and Subcutaneous Tissue Disorders
If these symptoms appear, consult your doctor immediately
Renal and Urinary Disorders
If these symptoms appear, consult your doctor immediately
Isolated Cases
Hepatobiliary Disorders
If these symptoms appear, consult your doctor immediately
Adverse Effects of Unknown Frequency (cannot be estimated from available data):
Skin and Subcutaneous Tissue Disorders
Reporting Adverse Effects
If you experience any type of adverse effect, consult your doctor or pharmacist, even if it is a possible adverse effect that is not listed in this leaflet. You can also report them directly through the Spanish Pharmacovigilance System for Human Use Medicines: https://www.notificaram.es. By reporting adverse effects, you can contribute to providing more information on the safety of this medicine.
Keep this medicine out of sight and reach of children.
Do not use this medicine after the expiration date that appears on the packaging after CAD. The expiration date is the last day of the month indicated.
Do not store at a temperature above 30°C.
Medicines should not be thrown down the drain or into the trash. Deposit the packaging and medicines that you no longer need in the SIGRE Point of the pharmacy. In case of doubt, ask your pharmacist how to dispose of the packaging and medicines that you no longer need. This way, you will help protect the environment.
Composition ofDiclofenac Cinfa
Core: lactose monohydrate, microcrystalline cellulose (E-460), corn starch, sodium croscarmellose, anhydrous colloidal silica, sodium lauryl sulfate, povidone (E-1201), talc (E-553b), magnesium stearate (E-470B).
Coating: hypromellose (E-464), ethyl acrylate and methacrylic acid copolymer (1:1) dispersion 30%, triethyl citrate (E-1505), talc (E-553b), titanium dioxide (E-171), yellow iron oxide (E-172), brown iron oxide (E-172).
Appearance of the Product and Package Contents
Cylindrical, biconvex tablets, light brown in color, coated and marked with the code "D50C".
They are presented in PVC-PVDC/Aluminum blisters. Each package contains 40 gastro-resistant tablets.
Marketing Authorization Holder and Manufacturer
Laboratorios Cinfa, S.A.
Carretera Olaz-Chipi, 10. Polígono Industrial Areta
31620 Huarte (Navarra) - Spain
Date of the Last Revision of this Leaflet:August 2025
Detailed and updated information on this medicine is available on the website of the Spanish Agency for Medicines and Health Products (AEMPS) http://www.aemps.gob.es/.
You can access detailed and updated information on this medicine by scanning the QR code included in the leaflet and packaging with your mobile phone (smartphone). You can also access this information at the following internet address: https://cima.aemps.es/cima/dochtml/p/62161/P_62161.html
QR code to: https://cima.aemps.es/cima/dochtml/p/62161/P_62161.html
The average price of DICLOFENAC CINFA 50 mg GASTRO-RESISTANT TABLETS in October, 2025 is around 1.65 EUR. Prices may vary depending on the region, pharmacy, and whether a prescription is required. Always check with a local pharmacy or online source for the most accurate information.
The best alternatives with the same active ingredient and therapeutic effect.
Discuss dosage, side effects, interactions, contraindications, and prescription renewal for DICLOFENAC CINFA 50 mg GASTRO-RESISTANT TABLETS – subject to medical assessment and local rules.